Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
ACADIAAssociation for Computer-Aided Design In Architecture
References in periodicals archive ?
Meeting the demand for extra passenger space, the 2014 Acadia can accommodate seven to eight people.
ACADIA and Sepracor established their research and development collaboration in January 2005 to develop new drug candidates from ACADIA's preclinical muscarinic receptor program for treatment of CNS disorders.
ACADIA noted that it takes seriously its responsibilities to create a harassment free workplace for all employees and believes it has long-standing appropriate policies and procedures in place to prevent harassment from occurring.
Acadia is a vertically-integrated organization whose investment experience includes debt restructuring, recapitalization, value-add re-leasing, and asset repositioning and redevelopment.
This news release is not an offer to sell or the solicitation of an offer to buy the shares of common stock of ACADIA.
ACADIA has a portfolio of four product candidates including pimavanserin, which is in Phase III clinical development as a treatment for Parkinson's disease psychosis.
CHICAGO -- Waud Capital Partners ("WCP") today announced that its portfolio company, Acadia Healthcare Company ("Acadia" or the "Company"), has acquired Youth & Family Centered Services, Inc.
CHICAGO -- Waud Capital Partners ("WCP") today announced the expansion of the management team at its portfolio company, Acadia Healthcare Company ("Acadia" or the "Company"), with the appointment of veteran behavioral healthcare executive Joey Jacobs as Chief Executive Officer.
ACADIA will host a conference call and webcast on Wednesday, November 10, 2004 at 4:30 p.
The anticipated proceeds from the private placement will provide ACADIA with additional resources to advance its Phase III pimavanserin program, including the ongoing Phase III trials in Parkinson's disease psychosis, and is expected to extend ACADIA's cash runway into 2013.
Aasen, Vice President and Chief Financial Officer of ACADIA Pharmaceuticals Inc.
With worldwide rights to pimavanserin and a focus on our ongoing Phase III program, we believe ACADIA is positioned on an attractive path forward for this product candidate.
Full browser ?